Sovos stands as an international leader in delivering tax, compliance, and trust solutions that empower businesses to confidently navigate a complex regulatory landscape.
With over 100,000 clients spanning more than 100 countries, including a significant portion of the Fortune 500, Sovos is a trusted partner for compliance solutions. The company processes upwards of three billion transactions each year across 19,000 tax jurisdictions worldwide. Supported by an extensive partner network comprising over 400 members, Sovos offers a matchless global resource for businesses across diverse industries and regions. Established in 1979, Sovos has expanded its operations throughout the Americas and Europe, and currently operates under the ownership of Hg and TA Associates. With a commitment to innovation, Sovos continues to adapt to the evolving needs of its clients, solidifying its position as a key player in the compliance landscape.
Learn more
Okyline is an Executable Data Design (EDD) platform that transforms validation contracts into executable operational assets for enterprise data quality.
Instead of multiplying specifications, custom validators, monitoring scripts, tests, and reporting layers, Okyline relies on a single readable contract shared across validation, quality control, and operational monitoring activities.
The contract itself becomes executable and directly drives deterministic validation, advanced business invariant verification, multi-format processing, data quality gates, operational metrics, and historical quality analytics.
Okyline validates APIs, enterprise events, files, streaming payloads, LLM structured outputs, and distributed data flows while continuously producing measurable quality indicators, completeness statistics, validation traces, and error propagation insights.
Because contracts are created from annotated sample data, validation rules remain immediately understandable for developers, architects, QA teams, integration specialists, and business analysts.
The Community Edition includes the public specification, a free Java validation runtime, a Claude AI assistant for contract generation, JSON Schema transpilation support, and a free online studio for executable JSON contracts.
The Enterprise Edition extends the same contract-centric model to native validation of JSON, JSONL, XML, CSV, FIXED, and EDI flows, combined with operational quality dashboards, data quality gates, and long-term quality tracking capabilities, all without requiring databases, warehouses, or centralized infrastructure.
Learn more
ClinCapture
ClinCapture aims to develop software that has the potential to save lives. Their innovative technology not only lowers the expenses associated with clinical trials but also enhances the efficiency of data collection while ensuring the confidentiality of patient information. Additionally, ClinCapture serves as a comprehensive platform that supports the assessment and advancement of drugs, biologics, and medical devices, which can address a diverse range of health issues. By prioritizing both cost-effectiveness and patient privacy, ClinCapture is dedicated to improving the overall landscape of clinical research.
Learn more
PathAI
At PathAI, our mission centers on improving patient outcomes by leveraging reliable AI-powered technology alongside strong partnerships, aiming to provide the most accurate diagnoses and effective treatments available. Our cutting-edge translational platform, backed by a team of proficient scientists, biostatisticians, and machine learning specialists, explores and analyzes novel cellular and tissue patterns to reveal pathology-related characteristics that lead to transformative insights across all phases of drug development and various therapeutic areas. By utilizing consistent and trustworthy technology, our systems seek to minimize observer variability while enhancing patient selection and stratification, thereby ensuring that the most appropriate patients participate in each trial, which significantly increases the prospects of successful results. Furthermore, our advanced technology determines the most precise cut points, which allows us to improve accuracy and increase the number of patients who positively test for biomarkers, ultimately facilitating the development of more effective treatments. This unwavering dedication to excellence not only places us at the forefront of healthcare innovation but also drives our commitment to shaping the future of medicine through advanced analytics and collaborative efforts, ensuring a healthier tomorrow for all.
Learn more
